Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/20/11 → 9/1/15 |
Funding
- Takeda Vaccines, Inc.: $207,578.00
Protocol Number: INV-DEN-104; A Randomized, Phase 1b Study to Investigate the Safety and Immunogenicty of Various Schedules of Tetravalent Chimeric Dengue Vaccine in Healthy Adult Volunteers Between the Ages of 18-45 Years
- Rupp, Richard (PI)
Project: Research project